Stewart Camille L, Wilson Lauren, Hamm Aidan, Bartsch Christan, Boniface Megan, Gleisner Ana, Mitchell John D, Weyant Michael J, Meguid Robert, Gajdos Csaba, Edil Barish H, McCarter Martin
Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
Ann Surg Oncol. 2017 May;24(5):1414-1418. doi: 10.1245/s10434-016-5742-x. Epub 2017 Jan 5.
Many centers use botulinum toxin for chemical pyloroplasty in minimally invasive esophagectomies as prophylaxis against delayed gastric emptying. No previous studies have compared botulinum toxin injection with no pyloric intervention for patients treated with a combined laparoscopic and thoracoscopic approach. The authors hypothesized that chemical pyloroplasty does not improve outcomes for these patients.
The study investigated patients undergoing minimally invasive esophagectomies from September 2009 to June 2015. Delayed gastric emptying was defined as inability to tolerate a soft diet by postoperative day 10, as corroborated by esophagram, upper endoscopy, or both. Data were compared using Student's t test, χ analysis, and Mann-Whitney U test where appropriate.
The study identified 71 patients treated with minimally invasive esophagectomy: 35 patients with chemical pyloroplasty treated from September 2009 to January 2014 and 36 patients without pyloric intervention from February 2014 to June 2015. The groups were statistically similar in age, gender distribution, T stage, percentage of patients receiving neoadjuvant therapy, body mass index, preoperative weight loss, preoperative serum albumin, and preoperative placement of feeding tubes (all p > 0.05). The overall incidence of delayed gastric emptying was low in both groups: 8.6% (3/35) of the patients with chemical pyloroplasty versus 5.6% (2/36) of the patients with no pyloric intervention (p = 0.62). The two groups also did not differ significantly in the development of aspiration pneumonia or the need for pyloric intervention.
In a well-matched cohort study with a historical control group, use of botulinum toxin for chemical pyloroplasty in minimally invasive esophagectomies was not associated with improved outcomes related to the pylorus versus no pyloric intervention. Although preliminary, these data suggest that chemical pyloroplasty is not necessary in minimally invasive esophagectomy.
许多中心在微创食管切除术中使用肉毒杆菌毒素进行化学性幽门成形术,以预防胃排空延迟。此前尚无研究比较肉毒杆菌毒素注射与未进行幽门干预对采用腹腔镜联合胸腔镜手术治疗的患者的影响。作者推测化学性幽门成形术并不能改善这些患者的预后。
该研究调查了2009年9月至2015年6月期间接受微创食管切除术的患者。胃排空延迟定义为术后第10天仍无法耐受软食,食管造影、上消化道内镜检查或两者均证实。在适当情况下,使用学生t检验、χ分析和曼-惠特尼U检验对数据进行比较。
该研究共纳入71例行微创食管切除术的患者:2009年9月至2014年1月期间接受化学性幽门成形术的患者35例,2014年2月至2015年6月期间未进行幽门干预的患者36例。两组在年龄、性别分布、T分期、接受新辅助治疗的患者百分比、体重指数、术前体重减轻、术前血清白蛋白以及术前放置喂养管方面差异无统计学意义(所有p>0.05)。两组胃排空延迟的总体发生率均较低:化学性幽门成形术组为8.6%(3/35),未进行幽门干预组为5.6%(2/36)(p=0.62)。两组在吸入性肺炎的发生或幽门干预的需求方面也无显著差异。
在一项与历史对照组匹配良好的队列研究中,在微创食管切除术中使用肉毒杆菌毒素进行化学性幽门成形术与未进行幽门干预相比,在幽门相关预后方面并未改善。尽管这些数据是初步的,但表明在微创食管切除术中化学性幽门成形术并非必要。